Literature DB >> 766563

The periurethral aerobic flora in girls highly susceptible to urinary infections.

I Bollgren, J Winberg.   

Abstract

After the age of 5 years, normal children have but few aerobic gram-negative rods periurethrally. This study examines whether there is an abnormal periurethral colonization in urinary tract infection-prone girls during infection-free intervals, indicating a defective local defence. In 13 girls with a history of recurrent infection, daily bacterial samples were obtained from the periurethral area and from urine. Sampling continued until an infection eventually occurred. Seven girls contracted a urinary tract infection within 3-30 days. All were heavy colonized with gram-negative rods, often several species, before infection appeared. Serotyping of E. coli confirmed that it was the colonizing strain which later invaded the bladder. The findings suggest a local defect in the antibacterial defence of infection-prone individuals and gives strong evidence for ascending infection. Six girls remained uninfected during an observation period of 9-123 days. They all had a normal periurethral flora. A reasonable hypothesis would be that the same factor counteracted colonization and infection. Since abnormal periurethral colonization was not a constant phenomenon the postulated defect may vary. This might explain the fact that urinary tract infections often appear in quick succession, often followed by long infection-free intervals.

Entities:  

Mesh:

Year:  1976        PMID: 766563     DOI: 10.1111/j.1651-2227.1976.tb04411.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  28 in total

1.  Changes in periurethral microflora after antimicrobial drugs.

Authors:  K J Lidefelt; I Bollgren; C E Nord
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 2.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

3.  pap-2-encoded fimbriae adhere to the P blood group-related glycosphingolipid stage-specific embryonic antigen 4 in the human kidney.

Authors:  J F Karr; B J Nowicki; L D Truong; R A Hull; J J Moulds; S I Hull
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Pathogenesis of urinary tract infections--amoxicillin induces genital Escherichia coli colonization.

Authors:  B M Herthelius; K G Hedström; R Möllby; C E Nord; L Pettersson; J Winberg
Journal:  Infection       Date:  1988 Sep-Oct       Impact factor: 3.553

5.  Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis.

Authors:  T A Tartaglione; C R Johnson; P Brust; K Opheim; T M Hooton; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

6.  Lack of effect of trimethoprim and nitrofurantoin on colonization resistance in the vagina of monkeys.

Authors:  M Herthelius-Elman; R Möllby; C E Nord; J Winberg
Journal:  Infection       Date:  1992 Mar-Apr       Impact factor: 3.553

7.  Adhesion of uropathogenic Escherichia coli to epithelial cells from women with recurrent urinary tract infection.

Authors:  A J Schaeffer; J M Jones; J L Duncan; J S Chmiel; B J Plotkin; W S Falkowski
Journal:  Infection       Date:  1982       Impact factor: 3.553

8.  Amoxicillin promotes vaginal colonization with adhering Escherichia coli present in faeces.

Authors:  M Herthelius; R Möllby; C E Nord; J Winberg
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

9.  Elimination of vaginal colonization with Escherichia coli by administration of indigenous flora.

Authors:  M Herthelius; S L Gorbach; R Möllby; C E Nord; L Pettersson; J Winberg
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

10.  Experimental haematogenous pyelonephritis in mice with uropathogenic, enteropathogenic and enterotoxigenic Escherichia coli.

Authors:  K Kakar; S Sharma; P J Asnani; C K Banerjee; B K Sharma
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.